The first of the big pharmas reveal Q2 earnings, with Novartis warning its profits may decline as it spends more on marketing. As Hayley Platt reports, pharma has benefitted as a defensive sector post-Brexit but still faces big challenges.
Read more
No comments:
Post a Comment